Researchers, healthcare experts working to develop COVD-19 vaccine as death toll surges

Scientists at Beth Israel Deaconess Medical Center are in the early stages of developing a vaccine to treat COVID-19.

Read Article

Ending the Pandemic

“The stunning epidemiology and clinical features of COVID-19, particularly the potential for explosive and asymptomatic spread, increase the chance that a vaccine may actually be required to end this epidemic,” said Dan Barouch. Read Article

BIOQUAL Announces COVID-19 Vaccine Testing

BIOQUAL announces the development of programs for in-vivo testing of COVID-19 candidate vaccines. BIOQUAL’s efforts to develop animal models for COVID-19 began in February 2020 in collaboration with Dr. Dan Barouch at Beth Israel Deaconess Medical Center and the Ragon Institute, both affiliated with Harvard Medical School. Read More

WBUR’s All Things Considered Broadcast: March 30, 2020

Dr. Dan Barouch speaks with Lisa Mullins from WBUR about COVID-19 vaccine plans with Johnson & Johnson. Listen more

Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19

US and J & J commit $1b to coronavirus vaccine codeveloped by Beth Israel

Clinical trials are set to start by September, and if all goes well, it could be ready for emergency use early next year. Read Article

Here are some of the Mass. businesses and institutions on the front lines of the COVID-19 battle

“The industry in Massachusetts is going to the mat to fight this thing.” Read Article

How Does the Coronavirus Behave Inside a Patient?

“And, logically, the larger amount of virus should trigger more severe disease by prompting a brisker inflammatory response. But that is still speculative. The relationship between initial viral dose and severity remains to be seen.”- Dr. Dan Barouch. Read more

Beth Israel Launches Drug Study to Help COVID-19 Patients

Dr. Katy Stephenson speaks to NBC Boston about leading two clinical trials for a treatment for COVID-19 patients. See more

HIV cure at CROI: new data on antibodies, vaccines and genetically engineered T-cells

Pre-conference Community HIV Cure Research Workshop outlines the results. Read Article